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Abstract
In order to improve culture media and to discover potential drug targets, uptake of an acidic, a basic, and an aromatic
amino acid were investigated. Current culture systems, axenic or co-cultivation with mammalian cells, do not provide either
the quantity or quality of cells needed for biochemical studies of this organism. Insight into nutrient acquisition can be
expected to lead to improved culture media and improved culture growth. Aspartic acid uptake was directly related to
substrate concentration, Q10 was 1.10 at pH 7.4. Hence the organism acquired this acidic amino acid by simple diffusion.
Uptake of the basic amino acid arginine and the aromatic amino acid tyrosine exhibited saturation kinetics consistent with
carrier-mediated mechanisms. Kinetic parameters indicated two carriers (Km = 22.8 þ 2.5 WM and Km = 3.6 þ 0.3 mM) for
arginine and a single carrier for tyrosine (Km = 284 þ 23 WM). The effects of other L-amino acids showed that the tyrosine
carrier was distinct from the arginine carriers. Tyrosine and arginine transport were independent of sodium and potassium
ions, and did not appear to require energy from ATP or a proton motive force. Thus facilitated diffusion was identified as the
mechanism of uptake. After 30 min of incubation, these amino acids were incorporated into total lipids and the sedimentable
material following lipid extraction; more than 90% was in the cellular soluble fraction. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Pneumocystis carinii is an opportunistic extracellu-
lar pathogen of the lung alveolus, and the etiologic
agent of P. carinii pneumonia (PcP). The infection
causes morbidity and mortality in immunosup-
pressed patients such as those with AIDS. Pentam-
idine and a combination of trimethoprim and sulfa-
methoxazole (TMP/SMZ, Bactrim) are the main
treatments of choice for PcP, but these can cause
severe side e¡ects in some patients [1]. Research on
the organism has been hampered by the lack of an
axenic culture protocol that provides large numbers
of organisms to study [2]. Axenic long-term cultiva-
tion has recently been achieved [3], but additional
work is required to improve organism proliferation
and culture growth. With only a few exceptions [4],
most endogenous metabolic and biosynthetic pro-
cesses as well as exogenous nutrient acquisition
mechanisms have yet to be examined in P. carinii.
The slow progress in the development of axenic cul-
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ture methods has in part been responsible for this
lack of information. Examination of the pathogen’s
membrane transport processes may reveal attractive
chemotherapeutic targets. Such studies can also pro-
vide data on the mechanisms by which exogenous
nutrients are taken up, and this kind of information
may be useful for improving culture media formula-
tions.
Amino acid in£ux and e¥ux are essential for cel-
lular homeostasis because they play important roles
in a multitude of fundamental functions such as pro-
tein and lipid synthesis, osmoregulation, cell growth
and development, and energy production. In many
cell types, selective permeability of biomembranes to
water-soluble solutes such as amino acids have been
demonstrated, and have shown to be facilitated by
protein carrier molecules. Cells commonly have a
carrier system for acidic amino acids, and a separate
one for the basic amino acids. More than one carrier
of the neutral amino acids is often detected in organ-
isms. Prokaryotes [5], the yeasts Saccharomyces [6,7]
and Schizosaccharomyces [8^11], Leishmania [12,13],
Trypanosoma [14,15], and mammalian cells [16] pos-
sess several amino acid transporters; most that have
been studied function by energy-requiring active
mechanisms that transport these compounds against
a chemical gradient.
Recently it was shown that, unlike many other
lower eukaryotes analyzed, P. carinii did not take
up the neutral amino acids leucine, glutamine, and
serine by active transport. These compounds were
transported by facilitated di¡usion, and utilized a
common carrier system (M. Basselin, Y.H. Qiu,
K.J. Lipscomb, E.S. Kaneshiro, unpublished results).
In the present study, the mechanisms by which P.
carinii takes up aspartic acid (acidic), arginine (ba-
sic), and tyrosine (aromatic) were investigated to
provide a better overview of how various groups of
amino acids are transported by this important op-
portunistic pathogen.
2. Materials and methods
2.1. Chemicals
L-[3,5-14C]Tyrosine (43 Ci/mmol) was purchased
from Amersham (Piscataway, NJ, USA).
L-[2,3,4,5-3H]Arginine monohydrochloride (45 Ci/
mmol) and L-[2,3-3H]aspartic acid (28 Ci/mmol)
were from American Radiolabeled Chemicals (Saint
Louis, MO, USA). L-Aspartic acid, L-arginine, L-ty-
rosine, ouabain, valinomycin, choline chloride, lith-
ium chloride, salicylhydroxamic acid (SHAM), car-
bonyl cyanide m-chlorophenyl hydrazone (CCCP),
gramicidin, N,NP-dicyclohexylcarbodiimide (DCCD),
and bovine serum albumin were from Sigma-Aldrich
(Saint Louis, MO, USA). Potassium cyanide (KCN)
and sodium azide were obtained from Fisher Scien-
ti¢c Co. (Spring¢eld, NJ, USA).
2.2. Organisms
P. carinii f. sp. carinii was isolated from the lungs
of rats that developed PcP using the Boylan and
Current [17] corticosteroid-immunosuppressed ani-
mal model. Brie£y, viral antibody-negative female
Lewis rats (Harlan Sprague^Dawley, Indianapolis,
IN, USA) were immunosuppressed with methylpred-
nisolone acetate (Depo-Medrol; Upjohn Co., Kala-
mazoo, MI, USA) and were twice inoculated intra-
tracheally with 106^107 mixed-life-cycle stages of
cryopreserved organisms [18]. Lung homogenates
containing P. carinii that were used for inoculation
into rats were prepared under aseptic conditions in
the absence of antibiotics [18]. Aliquots of these
preparations were cryopreserved and only those
that tested negative for common bacteria (Mueller
Hinton agar, Difco, Detroit, MI, USA) and fungi
(Sabouraud dextrose agar, Difco) were used for in-
fecting rats. After 8^10 weeks of immunosuppres-
sion, moribund rats were killed and their lungs
were perfused, excised, and cut into small pieces.
The organisms were isolated and puri¢ed accord-
ing to the Kaneshiro et al. protocol [18]. Brie£y, lung
pieces were homogenized (Stomacher; Tekmar, Cin-
cinnati, OH, USA) with the mucolytic sulfhydryl
agent glutathione, which caused the detachment of
organisms from host cells and other P. carinii organ-
isms. Puri¢cation involved sieving and a series of
centrifugation steps at di¡erent speeds, followed by
membrane micro¢ltration. The absence of host con-
taminants was demonstrated by microscopic, bio-
chemical, and immunochemical analyses; the prepa-
rations were found to be 95^100% pure [18]. The
organism preparations were also shown to be
BBAMEM 78069 21-3-01
M. Basselin et al. / Biochimica et Biophysica Acta 1511 (2001) 349^359350
s 99% and 100% pure with respect to potential bac-
terial and fungal contaminants, respectively. The P.
carinii used for biochemical studies were prepared
under normal open-laboratory bench conditions,
thus the ¢nal preparations were analyzed for micro-
bial contamination that occur during these routine
isolation and puri¢cation procedures. No fungal col-
onies were detected in the analyses of six separate
preparations after incubation overnight at room tem-
perature (0% fungal contamination). The same prep-
arations tested for bacterial contaminants were incu-
bated at 37‡C, and then the colonies were counted.
The contamination from bacteria was calculated with
respect to the number of P. carinii organisms. The
results indicated an average of 0.065 þ 0.033% bacte-
ria (s 99% P. carinii) ; the highest value observed
was 0.19% bacteria (s 99% P. carinii).
These preparations contained 10^30% cystic forms
and 80^95% viable organisms [19]. Process control
pellets resulting from subjecting the lungs of a single
normal, untreated rat or an immunosuppressed, un-
infected rat to the same isolation and puri¢cation
protocol, did not produce visible pellets after the
¢nal centrifugation step. The highest (not average)
total protein remaining in the centrifuge tube was
6 300 Wg (n = 10) [18]. In contrast, the volume of
¢nal puri¢ed P. carinii organism pellets isolated
from a single infected rat (108^109 organisms) is
0.3^0.4 ml containing approximately 5 mg protein
[18].
2.3. Amino acid uptake analyses and incorporation
Organisms (108^109) were centrifuged at 926Ug
for 10 min at 4‡C and then the pellet was resus-
pended in a HEPES-bu¡ered solution (100 mM
HEPES, 1.8 mM CaCl2, 0.85% NaCl) supplemented
with 2% glucose at pH 7.4 at a density of approx-
imately 5U107 organisms/ml. Organism suspensions
(0.8 ml) were incubated with 2^5 WCi L-[3,5-14C]ty-
rosine, 2^5 WCi L-[2,3,4,5-3H]arginine HCl, 2^5 WCi
L-[2,3-3H]aspartic acid, plus or minus other non-ra-
dioactive amino acids at the concentrations indicated
in the text. After 30 min at 37‡C, the suspensions
were centrifuged, washed twice with 10 ml of
HEPES-bu¡ered solution, centrifuged into a packed
pellet and then the lipids were extracted. The 30-min
incubation period was selected since uptake of amino
acids is slow and shorter times did not result in suf-
¢cient radioactivity in cells to perform experiments
using the same organism preparation for testing dif-
ferent incubation times, substrate concentrations, in-
hibitors and untreated controls. One-minute incuba-
tions with 1 WCi tritiated aspartate, arginine, or
tyrosine resulted in only 6 50^175 total cpm (107
organisms). Also, a 30-min incubation enabled the
detection of incorporation into lipids and proteins.
The e¡ects of ionophores and inhibitors on amino
acid transport was studied by incubating cells with
the compounds for 10 min prior to performing the
uptake assays.
Total lipids were extracted according to the meth-
od of Bligh and Dyer [19], and puri¢ed by biphasic
partitioning as described by Folch et al. [20]. Ali-
quots of the pellet fraction, lower organic phase
and upper aqueous phase were mixed with 5 ml of
liquid scintillation £uid to determine the radioactiv-
ity incorporated into water-soluble material, ex-
tracted lipids, and material in the pellet obtained
following lipid extraction. Counting e⁄ciencies
were 45 and 94% for [3H] and [14C], respectively.
Protein concentration was measured by the meth-
od of Lowry et al. [21] with bovine serum albumin as
a standard. The results were expressed in pmol of
amino acid/mg of P. carinii total proteins/min. Sta-
tistical analyses and plotting of data were performed
using Microsoft Excel 2000. Values of apparent ki-
netic parameters were resolved using the method of
Spears et al. [22] when two transporters were de-
tected for a single amino acid. Temperature coe⁄-
cient (Q10) values were calculated by the van’t Ho¡
equation Q10 = (k2/k1)10=t23t1 .
Inhibitor compound and amino acids that were
tested for their e¡ects on the uptake of arginine
and tyrosine were not analyzed using broad ranges
of concentration. For this report, other amino acids
and inhibitor compounds were considered e¡ective if
they decreased the uptake of the amino acid of in-
terest by 70% of control values. Inhibition by 70% of
control, without increasing inhibitor concentration
or other experimental conditions, was a su⁄ciently
substantial value to be considered a real e¡ect.
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3. Results
3.1. Uptake of the acidic amino acid L-aspartic acid
The time course for the uptake of 1 mM aspartic
acid at pH 7.6 was linear up to 45 min (Fig. 1A).
Aspartate uptake was then measured for 30 min us-
ing 0.22 WM to 5 mM substrate at pH 7.4 and from
0.09 WM to 20 mM substrate at pH 5.5. The plot of
the initial velocity against the concentration of as-
partic acid was linear (Fig. 1B,C). The uptake of
aspartic acid was directly related to the substrate
concentration; saturation was not demonstrable.
These results indicating adherence to Fick’s Law
showed that this acidic amino acid was taken up
by P. carinii by simple di¡usion; a carrier was not
involved. The values of the di¡usion constant could
be calculated from the slopes of the linear plots at
both pH values. The permeability of the plasma
membrane appeared to be signi¢cantly a¡ected by
the extracellular pH, with the di¡usion constant in-
creasing strongly at pH 5.5. Addition of 2.5 and
5 mM glutamic acid did not inhibit the di¡usion of
1 mM aspartic acid at pH 7.4 (93.1 and 91.5%, re-
spectively of that without glutamate addition). Sim-
ilar results were obtained at pH 5.5.
The e¡ects of temperature on aspartate uptake
were analyzed at pH 7.4 and pH 5.5. Cell suspen-
sions were held on ice (4‡C) and uptake was com-
pared to those at 37‡C. The Q10 values were 1.10 at
pH 7.4 and 1.34 at pH 5.5, which are consistent with
the e¡ects of temperature on physical processes.
After 30 min of incubation, 91.3% of the radio-
activity from aspartic acid was found in the cytosolic
soluble fraction. Radioactivity from aspartate was
incorporated into total extractable lipids (3.1%),
and in the pellet comprised of proteins and other
material after total lipids had been extracted (5.6%).
3.2. Transport of the basic amino acid L-arginine
Arginine uptake from 1- to 60-min incubation pe-
riods was measured; uptake was approximately line-
ar during the ¢rst 35 min (Fig. 2A), therefore subse-
quent experiments were standardized to 30-min
incubations. The uptake at di¡erent substrate con-
centrations was determined using 0.125 WM to 15
mM of arginine. The uptake was saturable (Fig.
2B), indicating that uptake was not by simple di¡u-
sion but was by facilitated transport mechanisms.
Two separate arginine transport systems were de-
tected by evaluating uptake rates using the Eadie^
Hofstee plot (Fig. 2C). The Km values for the high-
Fig. 1. Kinetics of aspartic acid transport by P. carinii. Time
course of aspartic acid uptake was measured between 1 and 60
min at a substrate concentration of 1 mM, pH 7.4. Closed and
open symbols represent values from two independent experi-
ments (A). The rate of aspartic acid uptake was measured over
the concentration range of 0.22 WM to 5 mM at pH 7.4 for 30
min at 37‡C (B) and between 0.09 WM and 20 mM aspartic
acid at pH 5.5 (C). Each point in B and C represents the
means þ S.E.M. of three independent experiments.
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a⁄nity and low-a⁄nity transporters were 22.8 þ 2.5
WM and 3.6 þ 0.3 mM, respectively. The velocities of
the carriers at Km were 2.15 þ 0.07 and 128 þ 7 pmol/
mg protein/min, respectively. The Vmax values were
2.45 þ 0.17 pmol/mg protein/min and 217 þ 9 pmol/
mg protein/min, respectively. The Km values for ly-
sine uptake in the yeasts Agaricus (32 WM) [23] and
Schizosaccharomyces pombe (26 WM) [9], the £agel-
lated protozoan parasites Leishmania (15 WM) [13],
Trypanosoma (25 WM) [14], and Giardia (15 WM) [24]
were comparable to that of the high-a⁄nity P. carinii
arginine transporter. The Km value for lysine uptake
by the low-a⁄nity transporter in S. pombe was 1.1
mM [7], which was lower than that of the low-a⁄nity
P. carinii arginine transporter, but in both organisms
the Km values of the low-a⁄nity basic amino acid
transporters were in the millimolar ranges.
Temperature-sensitivity for arginine uptake by
P. carinii was demonstrated. When the organism sus-
pensions were held on ice, transport was inhibited.
Uptake by the high-a⁄nity transporter was only
15 þ 6% of that measured at 37‡C, and uptake by
the low-a⁄nity transporter was 19 þ 5% of the 37‡C
control. The calculated Q10 values for the high- and
low-a⁄nity transporters for the basic amino acid ar-
ginine were 1.78 and 1.65, respectively. These were
not like the low values typical of physical processes,
such as that of uptake of the acidic amino acid as-
partic acid shown above. However, these Q10 values
were not typical of enzymatic and transport process-
es such as that clearly shown for tyrosine (see below).
In addition to its interaction with its carrier, the
charge on this basic amino acid may alter its trans-
location rate by physical interactions at or within the
cell surface membrane.
After 30-min incubation with exogenous radiola-
beled arginine, the pellet obtained after lipid extrac-
tion, which included cellular proteins contained 3.2%
of the total radioactivity in the organisms. Radioac-
tivity was also incorporated into total extractable
cellular lipids (2.7%); however, most activity was
found in the cytosolic soluble fraction (94.1%).
The basic amino acid lysine inhibited both of the
arginine transporters (Table 1). The neutral amino
acid leucine had a slight a¡ect on arginine uptake;
it inhibited only the high-a⁄nity arginine transport-
er. Leucine inhibited this arginine transporter by 51%
using a leucine/arginine ratio of 8.7. Another neutral
amino acid glutamine was tested; it did not have a
particularly notable e¡ect on the high- and low-a⁄n-
ity arginine transport systems. The acidic amino acid
aspartic acid and the aromatic phenylalanine exhib-
ited no e¡ects on the uptake of arginine by P. carinii
(Table 1).
Arginine uptake by P. carinii was not altered by
KCN, azide, and azide plus SHAM, indicating that
Fig. 2. Kinetics of arginine transport by P. carinii. (A) Time
course of arginine uptake was measured between 1 and 60 min
at a substrate concentration of 1.5 WM. Closed and open sym-
bols represent two independent experiments. (B) The rate of ar-
ginine uptake was analyzed at pH 7.4 at varying substrate con-
centrations using 30-min incubations. (C) Eadie^Hofstee plots
were used to determine the kinetic parameters for the two
transporters. Each point represents the mean þ S.E.M. of three
separate experiments.
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uptake did not require energy from ATP generated
from mitochondrial reactions (Table 2). However, it
cannot be ruled out that there are su⁄cient levels of
ATP in the cells generated from glycolysis to provide
energy for arginine transport. These inhibitor com-
pounds were also tested using 1-min incubations to
examine arginine uptake under conditions that min-
imize the potential e¡ects of radiolabeled arginine
e¥ux from cells. The same results were obtained as
those using 30-min incubations (data not shown).
The inhibitor of the Na+K ATPase/pump ouabain
and the K ionophore valinomycin also did not have
an e¡ect on arginine uptake. Substitution of sodium
ions by choline did not alter arginine transport
(90 þ 6% and 113 þ 6% of control for the high- and
low-a⁄nity transporters, respectively). These data
showed that arginine transport did not require so-
dium or potassium. The inhibitor of proton trans-
location DCCD and the proton ionophore CCCP
both showed no inhibitory activity on arginine up-
take by P. carinii, demonstrating that arginine up-
take by this organism did not involve proton trans-
port (Table 2).
3.3. Uptake of the aromatic amino acid L-tyrosine
Experiments on the rate of tyrosine uptake were
performed using incubation times between 1 and 60
min (Fig. 3A). Uptake rate was constant up to 40
min of incubation, thus subsequent experiments on
kinetic parameters and inhibition studies were stan-
dardized for 30-min incubation times. The rate of
tyrosine uptake as a function of substrate concentra-
tion was tested from 1.4 WM to 5 mM. Saturation
was observed indicating that tyrosine transport was
carrier-mediated (Fig. 3B). The apparent kinetic pa-
rameters were calculated after linear transformation
using Lineweaver^Burk and Eadie^Hofstee plots
(Fig. 3C,D). The values were 284 þ 23 WM for Km
and 93.4 þ 0.6 pmol/mg protein/min for Vmax. The
uptake velocity for tyrosine at Km was 35.2 þ 0.8
pmol/mg protein/min. The Km for tyrosine was sim-
Table 2
E¡ect of inhibitors on arginine uptake by P. carinii
Inhibitor compound Inhibitor concentration Arginine uptake (percent of untreated control)
high-a⁄nity carrier 1 low-a⁄nity carrier 2
Azide 1 mM 98 þ 3 100 þ 6
Azide+SHAM 1 mM+1 mM 101 þ 3 95 þ 4
KCN 1 mM 96 þ 3 89 þ 2
Ouabain 1 mM 105 þ 4 101 þ 10
DCCD 100 WM 96 þ 5 117 þ 8
CCCP 50 WM 92 þ 6 83 þ 2
Valinomycin 10 WM 86 þ 3 119 þ 5
Organism suspensions were preincubated with the inhibitor compounds for 10 min prior to measuring uptake for a 10-min period. Ar-
ginine concentrations of 23 WM and 3.6 mM were used to analyze carrier 1 and carrier 2, respectively. Velocities were normalized to
percent of control (absence of inhibitor). Values are expressed as means þ S.E.M. of percent control values from three independent ex-
periments.
Table 1
E¡ects of amino acids on arginine uptake by P. carinii
Amino acid added Arginine uptake (percent of control)
high-a⁄nity
carrier 1
low-a⁄nity
carrier 2
None (control) 100 100
Lysine 58 þ 2 71 þ 2
(200 WM) 56 þ 3 ^
(15 mM) ^ 48 þ 3
Glutamine 79 þ 2 91 þ 4
(200 WM) 81 þ 3 ^
Leucine 77 þ 4 101 þ 5
(200 WM) 49 þ 2 ^
Phenylalanine 108 þ 5 78 þ 3
Aspartic acid 102 þ 5 103 þ 2
Uptake by both the high-a⁄nity and low-a⁄nity arginine car-
riers were examined at substrate concentrations of 23 WM and
3.6 mM, respectively. Incubations of P. carinii suspensions with
radiolabeled arginine was performed at pH 7.4 for 30 min in
the absence or the presence of another amino acid at concentra-
tions of 100 WM (high-a⁄nity carrier 1) or 10 mM (low-a⁄nity
carrier 2). Results in each experiment were normalized to per-
cent of control (velocity at Km). Values are expressed as means
of the percent of control values þ S.E.M. of three independent
experiments.
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ilar to that found in the ¢ssion yeast S. pombe, which
was reported to be about 200 WM [8].
When P. carinii organism suspensions were held
on ice, transport was reduced to 8.3 þ 1.1% of con-
trols measured at 37‡C. The Q10 for the uptake pro-
cess was 2.12, which was typical of those for enzyme
reactions and carrier-mediated transport.
To determine the substrate speci¢city of the trans-
porter, tyrosine uptake was studied in the presence of
other L-amino acids. The aromatic amino acids phen-
ylalanine and tryptophan inhibited tyrosine transport
by 77 and 76%, respectively. These results indicate
that these amino acids may be also taken up by P.
carinii via the same basic amino acid transporter
(Table 3). Interestingly, the neutral amino acid leu-
cine had an equally high inhibitory e¡ect and caused
Table 3
E¡ect of L-amino acids on L-tyrosine transport by P. carinii
Amino acid added
(2.5 mM)
Tyrosine transport
(percent of control)
None (control) 100
Tyrosine 14 þ 3
Phenylalanine 23 þ 3
Tryptophan 24 þ 2
Leucine 29 þ 4
Valine 36 þ 2
Serine (1.25 mM) 55 þ 3
Glutamine 73 þ 3
(5 mM) 52 þ 4
Proline 95 þ 4
Arginine 101 þ 4
Aspartic acid 116 þ 5
Uptake of radiolabeled tyrosine was determined using 280 WM
tyrosine (Km) at pH 7.4 for 30 min with or without another
amino acid. Velocity of tyrosine uptake was expressed as per-
centage of the velocity observed in the absence of another ami-
no acid (control). Values are means þ S.E.M. of three indepen-
dent experiments.
Fig. 3. Kinetics of tyrosine transport by P. carinii. (A) Time
course of tyrosine transport was studied between 1 and 60 min
using 5.55 WM tyrosine. Open and closed symbols represent val-
ues obtained in two di¡erent experiments. (B) The initial rate
of tyrosine transport was measured at pH 7.4 for 30 min using
varying substrate concentrations. (C) Kinetic parameters are
shown by the double reciprocal Lineweaver^Burk plot. (D) Ki-
netic parameters illustrated by the Eadie^Hofstee plot. Each
point in B, C and D represents the mean þ S.E.M. of three sep-
arate experiments
6
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a decrease in tyrosine transport by 71%. Other neu-
tral amino acids, valine, serine and glutamine had
less e¡ects decreasing tyrosine transport by 64, 45
and 27%, respectively. These results suggest that ty-
rosine may use a neutral amino acid transporter sys-
tem or that neutral and aromatic amino acids can
share a common transporter. The basic amino acid
arginine, the acidic amino acid aspartic acid, and the
cyclic amino acid proline did not alter tyrosine trans-
port (Table 3).
The requirements for tyrosine transporter function
were examined. Tyrosine uptake by P. carinii was
not a¡ected by either the Na/K ATPase inhibitor
ouabain or the K ionophore valinomycin (Table 4).
The HEPES-bu¡ered solution used for incubations
did not include K salts. Incubation of organisms
in a sodium-free bu¡ered solution (substituted by
145 mM choline) did not alter tyrosine uptake
(94% of control). Substitution of Na by 145 mM
lithium ions also had no e¡ect (97% of control).
These results indicated that tyrosine uptake by
P. carinii did not require extracellular sodium or po-
tassium.
Tyrosine uptake was una¡ected by 1- or 30-min
incubations with KCN or sodium azide, inhibitors
that block cellular respiration and hence the produc-
tion of ATP (data not shown). That P. carinii has a
functional alternative oxidase system is supported by
a number of experiments showing activity of the in-
hibitor SHAM on the organism [3,25,26]. Tyrosine
uptake was not altered by treatment with SHAM in
the presence of sodium azide. Together these results
suggested that the uptake of tyrosine by P. carinii did
not require energy from ATP generated by oxidative
phosphorylation.
The proton ionophore CCCP, the cation iono-
phore gramicidin, and the H-ATPase inhibitor
DCCD had only trivial e¡ects on tyrosine transport,
thus eliminating the possibility that tyrosine uptake
was by active transport or by tyrosine^H symport
mechanisms (Table 4).
After 30 min incubation with radiolabeled tyro-
sine, radioactivity was incorporated into lipids
(2.9%), the cellular pellet following lipid extraction
(1.7%), and in the cytosolic soluble fraction (95.4%).
4. Discussion
4.1. Amino acid uptake mechanisms in P. carinii
In many other cell types amino acid uptake occurs
at a high rate and is aided by energy-requiring active
transport mechanisms. Uptake of these compounds
is frequently linked with the translocation of an in-
organic ion. In contrast, aspartate, arginine and ty-
rosine uptake by P. carinii appear to be slow, and the
results from a separate study on neutral amino acids
(M. Basselin, Y.H. Qiu, K.J. Lipscomb, E.S. Kane-
shiro, unpublished data) and those reported here are
consistent with the absence of active transport mech-
anisms for concentrating these compounds against a
chemical gradient into the cells. Thus far, evidence
has been provided to support the following conclu-
sions: (i) aspartic acid, an acidic amino acid enters
the organism by simple di¡usion; (ii) arginine, a ba-
sic amino acid is taken up by facilitated di¡usion;
(iii) tyrosine, an aromatic amino acid is transported
by a carrier, and the mechanism is facilitated di¡u-
sion; (iv) neutral amino acids are transported by
facilitated di¡usion using a separate carrier system
(M. Basselin, Y.H. Qiu, K.J. Lipscomb, E.S. Kane-
shiro, unpublished data). With the exception of the
acidic amino acids, entry of an individual amino acid
into P. carinii is apparently mediated by a primary
transporter system, but some amino acids can also
use an alternate secondary carrier system. This sug-
gestion is supported by the strong inhibition exerted
Table 4
E¡ect of inhibitors on tyrosine uptake by P. carinii
Inhibitor Inhibitor
concentration
Tyrosine uptake (percent
of untreated control)
Azide 1 mM 96 þ 12
Azide+SHAM 1 mM+1 mM 93 þ 6
KCN 1 mM 85 þ 6
Ouabain 1 mM 108 þ 12
DCCD 100 WM 110 þ 9
CCCP 50 WM 90 þ 14
Valinomycin 10 WM 106 þ 16
Gramicidin 10 Wg/ml 74 þ 8
Pneumocystis organism suspensions were incubated with the in-
hibitor compounds for 10 min, prior to measuring radiolabeled
tyrosine uptake. In each experiment, velocities were normalized
to percent of control (absence of inhibitor compound). Values
are expressed as means þ S.E.M. of the percent of control val-
ues; n = 3.
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on a speci¢c transporter system (e.g. the tyrosine
carrier) by similar amino acids, but other types of
amino acids also have e¡ects. Also consistent with
this suggestion is the detection of two transporters
for the basic amino acid arginine. Leucine had mod-
erate inhibitory e¡ects on the high-a⁄nity arginine
uptake system (with no e¡ects on the low-a⁄nity
system), and strongly inhibited tyrosine uptake, sug-
gesting that this amino acid can enter cells via multi-
ple carrier systems. Since tyrosine and arginine did
not have an e¡ect on leucine uptake (M. Basselin,
Y.H. Qiu, K.J. Lipscomb, E.S. Kaneshiro, unpub-
lished data), this supports the suggestion that the
aromatic and basic amino acid transporters are dis-
tinct from the primary carrier utilized by leucine and
other neutral amino acids.
4.2. Comparison of the uptake rates of amino acids
and other nutrients
Pneumocystis e⁄ciently takes up lipid substrates
[27]. Uptake rates and apparent kinetic parameters
for palmitate and oleate suggest the mechanism may
be by facilitated transport [28], but detailed experi-
ments were not performed to determine whether up-
take of these fatty acids was uphill, required energy
or inorganic ions. Recently, the essential nature of
S-adenosylmethionine (SAM) in P. carinii nutrition
was demonstrated [29]; the organisms rapidly uti-
lized this compound, which is needed in several met-
abolic pathways. Uptake of SAM involved two car-
rier systems, which actively transported the
compound into cells against a chemical gradient.
Proton-gradient-driven active transport operates in
the uptake of amino acids into many organisms [5^
14,16]. The gene for a putative cell surface H-ATP-
ase was identi¢ed in P. carinii [30], and more re-
cently, it was reported that H-ATPase activity at
the cell surface regulates intracellular pH [31] and
plays a signi¢cant role in the regulation of the cell
surface membrane potential of this organism [32].
The involvement of a proton-motive force in nutrient
uptake by P. carinii appears plausible, but this has
yet to be experimentally demonstrated for any com-
pound. In a separate study, we demonstrated that
this putative P. carinii pump was not required for
uptake of serine, glutamine or leucine. In this report,
we eliminated the possibility that arginine, aspartic
acid and tyrosine are taken up by mechanisms in-
volving the H-ATPase/pump at the cell surface.
4.3. Nutritional aspects
Thus far, our results indicate that the uptake rates
of individual amino acids by P. carinii are all slower
than those of SAM [29] and fatty acids [28], and that
simple di¡usion and facilitated di¡usion, but not ac-
tive transport, are apparently su⁄cient. Only one
gene whose product may facilitate amino acid uptake
(amino acid permease) has been identi¢ed (by ex-
pressed sequence tag techniques) in the ongoing
Pneumocystis Genome Project (www.uky.edu/
projects/pneumocystis). Our experiments have identi-
¢ed at least three amino acid transporters. It is not
known whether this expressed amino acid permease
gene encodes any of the three amino acid carriers we
have thus far identi¢ed in this organism.
The slow uptake of exogenous amino acids and the
mechanisms operative in P. carinii may indicate that
the organism synthesizes de novo most, if not all of
its amino acids. Although experiments on amino acid
synthesis in this organism have not been systemati-
cally investigated, the identi¢cation of the arom gene
[33] suggests that, unlike mammals, P. carinii can
synthesize its own aromatic amino acids. In P. ca-
rinii, the arom gene encodes ¢ve shikimic acid path-
way enzymes. In other organisms examined, the
product of this pathway is chorismate, which is a
central precursor for various biosynthetic pathways
including aromatic amino acids.
Even if P. carinii synthesizes de novo its amino
acids, this does not preclude the possibility that exog-
enous amino acid supplementation can increase ax-
enic culture growth rates. Although not taken up by
active transport, exogenous amino acids are taken up
and incorporated into the organism’s distinct com-
plex molecules such as proteins, glycoproteins, and
lipids [4,28,34]. It is not surprising that serine was
incorporated into P. carinii lipids [34] (M. Basselin,
Y.H. Qiu, K.J. Lipscomb, E.S. Kaneshiro, unpub-
lished data) since it is the direct precursor of phos-
phatidylserine and the long chain base of sphingolip-
ids. However, all amino acids thus far examined
appear to be at least partially utilized by the organ-
ism for lipid biosynthesis; radioactivity was found in
the total lipid fraction in each case. In this study we
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found that twice the amount of radioactivity from
tyrosine was incorporated into total lipids compared
to the pellet (which includes substantial amounts of
protein) obtained by centrifugation following lipid
extraction.
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